MAPT and Alzheimer disease: In keeping with the finding that in vivo TSPO radioligand binding is increased in AD patients compared to controls [15, 16], we have previously shown histologically that TSPO expression increases with the progression of AD, and this may be linked to the increase in phosphorylated (p)Tau [12].